T1	PROC 44 54	Profilaxis
#1	AnnotatorNotes T1	C0199176; Prophylactic treatment; Therapeutic or Preventive Procedure
T2	DISO 61 83	infección por COVID-19
#2	AnnotatorNotes T2	C5203670; COVID19 (disease); Disease or Syndrome
T3	CHEM 88 105	hidroxicloroquina
#3	AnnotatorNotes T3	C0020336; hydroxychloroquine; Organic Chemical · Pharmacologic Substance
T4	DISO 150 158	contagio
#4	AnnotatorNotes T4	C0242781; disease transmission; Pathologic Function
T5	DISO 182 204	Infección por COVID-19
#5	AnnotatorNotes T5	C5203670; COVID19 (disease); Disease or Syndrome
T6	DISO 361 385	infección por SARS-CoV-2
#6	AnnotatorNotes T6	C5203670; COVID19 (disease); Disease or Syndrome
T7	PROC 268 292	consentimiento informado
#7	AnnotatorNotes T7	C0567423; Informed consent for procedure; Therapeutic or Preventive Procedure
T8	PROC 458 479	método anticonceptivo
#8	AnnotatorNotes T8	C0700589; Contraceptive methods; Therapeutic or Preventive Procedure
T9	DISO 761 769	COVID-19
#9	AnnotatorNotes T9	C5203670; COVID19 (disease); Disease or Syndrome
T10	PROC 593 617	consentimiento informado
#10	AnnotatorNotes T10	C0567423; Informed consent for procedure; Therapeutic or Preventive Procedure
T11	PROC 568 579	tratamiento
#11	AnnotatorNotes T11	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T12	PROC 653 664	tratamiento
#12	AnnotatorNotes T12	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T13	PROC 826 840	hospitalizados
#13	AnnotatorNotes T13	C0019993; Hospitalization; Health Care Activity
T14	PROC 886 897	tratamiento
#14	AnnotatorNotes T14	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T15	DISO 1142 1150	COVID-19
#15	AnnotatorNotes T15	C5203670; COVID19 (disease); Disease or Syndrome
T16	PROC 1113 1127	hospitalizados
#16	AnnotatorNotes T16	C0019993; Hospitalization; Health Care Activity
T17	PROC 1176 1187	tratamiento
#17	AnnotatorNotes T17	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T18	DISO 1338 1343	COVID
T19	DISO 855 863	COVID-19
#18	AnnotatorNotes T19	C5203670; COVID19 (disease); Disease or Syndrome
T20	PROC 1485 1495	serologías
#19	AnnotatorNotes T20	C0036743; Serologic tests; Laboratory Procedure
T21	ANAT 1633 1639	cornea
#20	AnnotatorNotes T21	C0010031; Cornea; Body Part, Organ, or Organ Component | C1278889; Entire cornea; Body Part, Organ, or Organ Component
T22	DISO 1576 1596	Síndrome de QT largo
#21	AnnotatorNotes T22	C0023976; Long QT Syndrome; Disease or Syndrome
T23	DISO 1599 1639	Enfermedades de la retina o de la cornea
T24	PROC 1642 1661	Filtrado glomerular
#22	AnnotatorNotes T24	C0017654; Glomerular Filtration Rate; Diagnostic Procedure
T25	DISO 1682 1701	disfunción hepática
#23	AnnotatorNotes T25	C0086565; Liver Dysfunction; Finding
T26	DISO 1719 1736	Hipersensibilidad
#24	AnnotatorNotes T26	C0020517; Hypersensitivity; Pathologic Function | C0429891; Hypersensitivity finding; Finding
T27	CHEM 1808 1818	medicación
#25	AnnotatorNotes T27	C0013227; Pharmaceutical Preparations; Pharmacologic Substance | C0456386; Medicament; Pharmacologic Substance
T28	CHEM 1832 1849	hidroxicloroquina
#26	AnnotatorNotes T28	C0020336; hydroxychloroquine; Organic Chemical · Pharmacologic Substance
T29	CHEM 1920 1930	medicación
#27	AnnotatorNotes T29	C0013227; Pharmaceutical Preparations; Pharmacologic Substance | C0456386; Medicament; Pharmacologic Substance
T30	CHEM 902 919	hidroxicloroquina
#28	AnnotatorNotes T30	C0020336; hydroxychloroquine; Organic Chemical · Pharmacologic Substance
T31	DISO 1048 1056	COVID-19
#29	AnnotatorNotes T31	C5203670; COVID19 (disease); Disease or Syndrome
T32	CHEM 1192 1209	hidroxicloroquina
#30	AnnotatorNotes T32	C0020336; hydroxychloroquine; Organic Chemical · Pharmacologic Substance
T33	PROC 1446 1449	PCR
#31	AnnotatorNotes T33	C0032520; Polymerase Chain Reaction; Molecular Biology Research Technique
T34	ANAT 1618 1624	retina
#32	AnnotatorNotes T34	C0035298; Retina; Body Part, Organ, or Organ Component | C1278894; Entire retina; Body Part, Organ, or Organ Component
T35	ANAT 1693 1701	hepática
#33	AnnotatorNotes T35	C0023884; Liver; Body Part, Organ, or Organ Component | C1278929; Entire liver; Body Part, Organ, or Organ Component
T36	CHEM 1742 1752	medicación
#34	AnnotatorNotes T36	C0013227; Pharmaceutical Preparations; Pharmacologic Substance | C0456386; Medicament; Pharmacologic Substance
T37	DISO 1767 1792	Interacción medicamentosa
T38	Date 12 16	2020
T39	LIVB 109 127	personal sanitario
#35	AnnotatorNotes T39	C0018724; Health Personnel; Professional or Occupational Group | C1704312; Health Professional; Professional or Occupational Group
T40	Spec_cue 140 149	riesgo de
T41	Age 237 255	mayores de 18 años
T42	Neg_cue 328 330	ni
T44	LIVB 403 419	mujeres fértiles
#36	AnnotatorNotes T44	C4324275; Woman of childbearing potential; Population Group
T46	Duration 529 540	los 3 meses
T48	LIVB 630 639	pacientes
#37	AnnotatorNotes T48	C0030705; Patients; Patient or Disabled Group
T49	LIVB 683 707	profesionales sanitarios
#38	AnnotatorNotes T49	C0018724; Health Personnel; Professional or Occupational Group
T50	Spec_cue 717 726	riesgo de
T51	LIVB 740 749	pacientes
#39	AnnotatorNotes T51	C0030705; Patients; Patient or Disabled Group
T53	LIVB 841 850	pacientes
#40	AnnotatorNotes T53	C0030705; Patients; Patient or Disabled Group
T54	Duration 928 934	un mes
T55	LIVB 939 955	Grupo de control
#41	AnnotatorNotes T55	C0009932; Control Group; Group
T56	LIVB 970 994	profesionales sanitarios
#42	AnnotatorNotes T56	C0018724; Health Personnel; Professional or Occupational Group
T57	Spec_cue 1004 1013	riesgo de
T58	LIVB 1027 1036	pacientes
#43	AnnotatorNotes T58	C0030705; Patients; Patient or Disabled Group
T60	LIVB 1128 1137	pacientes
#44	AnnotatorNotes T60	C0030705; Patients; Patient or Disabled Group
T61	Neg_cue 1156 1158	no
T62	Duration 1218 1224	un mes
T63	LIVB 1229 1245	Grupo de control
#45	AnnotatorNotes T63	C0009932; Control Group; Group
T64	LIVB 1260 1284	profesionales sanitarios
#46	AnnotatorNotes T64	C0018724; Health Personnel; Professional or Occupational Group
T65	Spec_cue 1294 1303	riesgo de
T66	LIVB 1317 1326	pacientes
#47	AnnotatorNotes T66	C0030705; Patients; Patient or Disabled Group
T67	LIVB 1382 1401	Mujeres embarazadas
#48	AnnotatorNotes T67	C0033011; Pregnant Women; Population Group
T68	LIVB 1404 1413	lactantes
#49	AnnotatorNotes T68	C4316174; Patients who are breastfeeding; Patient or Disabled Group
T69	LIVB 1463 1473	SARS-CoV-2
#50	AnnotatorNotes T69	C5203676; SARS-CoV-2; Virus
T70	LIVB 1511 1521	SARS-CoV-2
#51	AnnotatorNotes T70	C5203676; SARS-CoV-2; Virus
T73	Duration 1819 1826	crónica
#52	AnnotatorNotes T73	C0205191; chronic; Temporal Concept
T75	LIVB 375 385	SARS-CoV-2
#53	AnnotatorNotes T75	C5203676; SARS-CoV-2; Virus
T43	DISO 727 737	exposición
#54	AnnotatorNotes T43	C0260339; Encounter due to contact with or exposure to communicable diseases; Finding [ICD-10: Z20]
T45	DISO 1014 1024	exposición
#55	AnnotatorNotes T45	C0260339; Encounter due to contact with or exposure to communicable diseases; Finding [ICD-10: Z20]
T47	DISO 1304 1314	exposición
#56	AnnotatorNotes T47	C0260339; Encounter due to contact with or exposure to communicable diseases; Finding [ICD-10: Z20]
T76	PHYS 1390 1401	embarazadas
#57	AnnotatorNotes T76	C0032961; Pregnancy; Organism Function
T71	PROC 1703 1713	Child Pugh
#58	AnnotatorNotes T71	C3854424; Child-Pugh-Turcotte score; Laboratory Procedure
T52	LIVB 771 786	personal de UCI
#59	AnnotatorNotes T52	C0586850; Intensive care specialist; Professional or Occupational Group
T59	LIVB 1058 1073	personal de UCI
#60	AnnotatorNotes T59	C0586850; Intensive care specialist; Professional or Occupational Group
A1	Assertion T4 Speculated
A2	Assertion T6 Negated
A4	Assertion T43 Speculated
A5	Assertion T45 Speculated
A6	Assertion T47 Speculated
A7	Assertion T17 Negated
A8	Status T6 History_of
A9	Status T26 History_of
A10	Assertion T29 Contraindicated
A11	Status T33 History_of
#61	AnnotatorNotes T37	C0687133; Drug Interactions; Pathologic Function
#62	AnnotatorNotes T18	C5203670; COVID19 (disease); Disease or Syndrome
R1	Negation Arg1:T42 Arg2:T6	
R2	Negation Arg1:T61 Arg2:T17	
R3	Speculation Arg1:T57 Arg2:T45	
R4	Speculation Arg1:T50 Arg2:T43	
R5	Speculation Arg1:T65 Arg2:T47	
R6	Before Arg1:T1 Arg2:T2	
R7	Used_for Arg1:T3 Arg2:T1	
R8	Experiences Arg1:T39 Arg2:T1	
R9	Experiences Arg1:T39 Arg2:T72	
R10	Speculation Arg1:T40 Arg2:T4	
T72	Observation 132 149	elevado riesgo de
#63	AnnotatorNotes T72	C0332167; High risk of; Finding
R11	Before Arg1:T72 Arg2:T4	
R12	Before Arg1:T1 Arg2:T4	
R13	Overlap Arg1:T7 Arg2:T41	
R14	Causes Arg1:T75 Arg2:T6	
R15	Experiences Arg1:T44 Arg2:T8	
T74	Quantifier_or_Qualifier 480 486	fiable
R16	Has_Quantifier_or_Qualifier Arg1:T8 Arg2:T74	
T77	PROC 511 518	estudio
#64	AnnotatorNotes T77	C0008976; Clinical Trials; Research Activity
R17	Overlap Arg1:T8 Arg2:T77	
R18	Has_Duration_or_Interval Arg1:T8 Arg2:T46	
R19	After Arg1:T8 Arg2:T11	
R20	Experiences Arg1:T49 Arg2:T12	
R21	Experiences Arg1:T51 Arg2:T9	
R22	Experiences Arg1:T52 Arg2:T12	
R23	Experiences Arg1:T53 Arg2:T13	
R24	Experiences Arg1:T53 Arg2:T19	
R25	Experiences Arg1:T51 Arg2:T13	
R26	Experiences Arg1:T51 Arg2:T19	
R27	Experiences Arg1:T53 Arg2:T9	
T78	Quantifier_or_Qualifier 665 671	activo
#65	AnnotatorNotes T78	C0205177; Active; Qualitative Concept | C0679217; Active State; Idea or Concept
R28	Has_Quantifier_or_Qualifier Arg1:T12 Arg2:T78	
R29	Experiences Arg1:T49 Arg2:T14	
R30	Used_for Arg1:T30 Arg2:T14	
R31	Has_Duration_or_Interval Arg1:T30 Arg2:T54	
T79	Observation 712 726	alto riesgo de
#66	AnnotatorNotes T79	C0332167; High risk of; Finding
R32	Before Arg1:T79 Arg2:T43	
R33	Experiences Arg1:T49 Arg2:T79	
R34	Experiences Arg1:T52 Arg2:T79	
T80	Observation 999 1013	alto riesgo de
#67	AnnotatorNotes T80	C0332167; High risk of; Finding
R35	Before Arg1:T80 Arg2:T45	
R36	Experiences Arg1:T56 Arg2:T80	
R37	Experiences Arg1:T55 Arg2:T80	
R38	Experiences Arg1:T58 Arg2:T31	
R39	Experiences Arg1:T59 Arg2:T80	
R40	Experiences Arg1:T59 Arg2:T17	
R41	Experiences Arg1:T56 Arg2:T17	
R42	Used_for Arg1:T32 Arg2:T17	
R43	Has_Duration_or_Interval Arg1:T32 Arg2:T62	
R44	Experiences Arg1:T60 Arg2:T16	
R45	Experiences Arg1:T60 Arg2:T15	
R46	Experiences Arg1:T60 Arg2:T31	
R47	Experiences Arg1:T58 Arg2:T16	
R48	Experiences Arg1:T58 Arg2:T15	
R53	Experiences Arg1:T66 Arg2:T18	
T81	Observation 1289 1303	bajo riesgo de
#68	AnnotatorNotes T81	C5201228; Low risk; Finding
R54	Before Arg1:T81 Arg2:T47	
R55	Experiences Arg1:T64 Arg2:T81	
R56	Experiences Arg1:T67 Arg2:T76	
T82	Result_or_Value 1450 1458	positiva
#69	AnnotatorNotes T82	C1446409; Positive; Finding
R57	Has_Result_or_Value Arg1:T33 Arg2:T82	
R58	Causes Arg1:T69 Arg2:T82	
T83	Result_or_Value 1496 1505	positivas
#70	AnnotatorNotes T83	C1446409; Positive; Finding
R59	Has_Result_or_Value Arg1:T20 Arg2:T83	
R60	Causes Arg1:T70 Arg2:T83	
T84	CONC 1563 1572	inclusión
#71	AnnotatorNotes T84	C1512693; Inclusion; Qualitative Concept
R61	Overlap Arg1:T33 Arg2:T84	
R62	Overlap Arg1:T20 Arg2:T84	
R63	Location_of Arg1:T34 Arg2:T23	
R64	Location_of Arg1:T21 Arg2:T23	
#72	AnnotatorNotes T23	C0035309; Retinal Diseases; Disease or Syndrome | C0010034; Corneal Diseases; Disease or Syndrome
T85	Result_or_Value 1662 1672	< 30ml/min
R65	Has_Result_or_Value Arg1:T24 Arg2:T85	
R66	Location_of Arg1:T35 Arg2:T25	
T86	Result_or_Value 1714 1715	3
R67	Has_Result_or_Value Arg1:T71 Arg2:T86	
T87	Quantifier_or_Qualifier 1675 1681	Severa
#73	AnnotatorNotes T87	C1547227; Severe - Severity of Illness Code; Intellectual Product
R68	Has_Quantifier_or_Qualifier Arg1:T25 Arg2:T87	
R69	Causes Arg1:T36 Arg2:T26	
R70	Causes Arg1:T27 Arg2:T37	
R71	Causes Arg1:T28 Arg2:T37	
R72	Has_Duration_or_Interval Arg1:T27 Arg2:T73	
T88	Quantifier_or_Qualifier 1793 1798	mayor
#74	AnnotatorNotes T88	C0205164; Major; Qualitative Concept
R73	Has_Quantifier_or_Qualifier Arg1:T37 Arg2:T88	
T89	CONC 351 360	inclusión
#75	AnnotatorNotes T89	C1512693; Inclusion; Qualitative Concept
R75	Overlap Arg1:T6 Arg2:T89	
R76	Experiences Arg1:T39 Arg2:T4	
R77	Experiences Arg1:T64 Arg2:T47	
R78	Experiences Arg1:T55 Arg2:T45	
R79	Experiences Arg1:T49 Arg2:T43	
R80	Experiences Arg1:T39 Arg2:T2	
#76	AnnotatorNotes T74	C3858758; Reliable; Functional Concept
R81	Experiences Arg1:T44 Arg2:T11	
A3	Experiencer T39 Patient
A12	Experiencer T44 Patient
A13	Experiencer T48 Patient
A14	Experiencer T49 Patient
A15	Experiencer T51 Patient
A16	Experiencer T52 Patient
A17	Experiencer T53 Patient
A18	Experiencer T55 Patient
A19	Experiencer T56 Patient
A20	Experiencer T58 Patient
A21	Experiencer T59 Patient
A22	Experiencer T60 Patient
A23	Experiencer T63 Patient
A24	Experiencer T64 Patient
A25	Experiencer T66 Patient
A26	Experiencer T67 Patient
A27	Experiencer T68 Patient
A28	Assertion T44 Hypothetical
